ID   SRS10_HUMAN             Reviewed;         262 AA.
AC   O75494; A6NFM6; A6NI42; A6NIU7; B4DJP9; O60572; Q5JRH9; Q5JRI0; Q5JRI2;
AC   Q5JRI3; Q5JRI4; Q96G09; Q96P17;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   28-JAN-2026, entry version 226.
DE   RecName: Full=Serine/arginine-rich splicing factor 10;
DE   AltName: Full=40 kDa SR-repressor protein;
DE            Short=SRrp40;
DE   AltName: Full=FUS-interacting serine-arginine-rich protein 1;
DE   AltName: Full=Splicing factor SRp38;
DE   AltName: Full=Splicing factor, arginine/serine-rich 13A;
DE   AltName: Full=TLS-associated protein with Ser-Arg repeats;
DE            Short=TASR;
DE            Short=TLS-associated protein with SR repeats;
DE   AltName: Full=TLS-associated serine-arginine protein;
DE            Short=TLS-associated SR protein;
GN   Name=SRSF10; Synonyms=FUSIP1, FUSIP2, SFRS13A, TASR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND INTERACTION WITH FUS.
RC   TISSUE=Leukemia;
RX   PubMed=9774382; DOI=10.1074/jbc.273.43.27761;
RA   Yang L., Embree L.J., Tsai S., Hickstein D.D.;
RT   "Oncoprotein TLS interacts with serine-arginine proteins involved in RNA
RT   splicing.";
RL   J. Biol. Chem. 273:27761-27764(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10779324; DOI=10.1128/mcb.20.10.3345-3354.2000;
RA   Yang L., Embree L.J., Hickstein D.D.;
RT   "TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-
RT   arginine proteins.";
RL   Mol. Cell. Biol. 20:3345-3354(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11684676; DOI=10.1074/jbc.m103967200;
RA   Cowper A.E., Caceres J.F., Mayeda A., Screaton G.R.;
RT   "Serine-arginine (SR) protein-like factors that antagonize authentic SR
RT   proteins and regulate alternative splicing.";
RL   J. Biol. Chem. 276:48908-48914(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, AND
RP   PHOSPHORYLATION.
RX   PubMed=12419250; DOI=10.1016/s0092-8674(02)01038-3;
RA   Shin C., Manley J.L.;
RT   "The SR protein SRp38 represses splicing in M Phase cells.";
RL   Cell 111:407-417(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], ALTERNATIVE SPLICING (ISOFORMS 2
RP   AND 3), AND TISSUE SPECIFICITY.
RX   PubMed=11891055; DOI=10.1016/s0378-1119(02)00382-7;
RA   Clinton J.M., Chansky H.A., Odell D.D., Zielinska-Kwiatkowska A.,
RA   Hickstein D.D., Yang L.;
RT   "Characterization and expression of the human gene encoding two
RT   translocation liposarcoma protein-associated serine-arginine (TASR)
RT   proteins.";
RL   Gene 284:141-147(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 5).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Muscle, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH SNRNP70 AND TRA2B.
RX   PubMed=14765198; DOI=10.1038/nature02288;
RA   Shin C., Feng Y., Manley J.L.;
RT   "Dephosphorylated SRp38 acts as a splicing repressor in response to heat
RT   shock.";
RL   Nature 427:553-558(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129; SER-131 AND SER-133, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-133; SER-158 AND
RP   SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; SER-108; SER-131 AND
RP   SER-133, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158 AND SER-160
RP   (ISOFORM 4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-106; SER-108;
RP   SER-129; SER-131 AND SER-133, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-133, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH YTHDC1.
RX   PubMed=26876937; DOI=10.1016/j.molcel.2016.01.012;
RA   Xiao W., Adhikari S., Dahal U., Chen Y.S., Hao Y.J., Sun B.F., Sun H.Y.,
RA   Li A., Ping X.L., Lai W.Y., Wang X., Ma H.L., Huang C.M., Yang Y.,
RA   Huang N., Jiang G.B., Wang H.L., Zhou Q., Wang X.J., Zhao Y.L., Yang Y.G.;
RT   "Nuclear m(6)A reader YTHDC1 regulates mRNA splicing.";
RL   Mol. Cell 61:507-519(2016).
CC   -!- FUNCTION: Splicing factor that in its dephosphorylated form acts as a
CC       general repressor of pre-mRNA splicing (PubMed:11684676,
CC       PubMed:12419250, PubMed:14765198). Seems to interfere with the U1 snRNP
CC       5'-splice recognition of SNRNP70 (PubMed:14765198). Required for
CC       splicing repression in M-phase cells and after heat shock
CC       (PubMed:14765198). Also acts as a splicing factor that specifically
CC       promotes exon skipping during alternative splicing (PubMed:26876937).
CC       Interaction with YTHDC1, a RNA-binding protein that recognizes and
CC       binds N6-methyladenosine (m6A)-containing RNAs, prevents SRSF10 from
CC       binding to its mRNA-binding sites close to m6A-containing regions,
CC       leading to inhibit exon skipping during alternative splicing
CC       (PubMed:26876937). May be involved in regulation of alternative
CC       splicing in neurons, with isoform 1 acting as a positive and isoform 3
CC       as a negative regulator (PubMed:12419250).
CC       {ECO:0000269|PubMed:11684676, ECO:0000269|PubMed:12419250,
CC       ECO:0000269|PubMed:14765198, ECO:0000269|PubMed:26876937}.
CC   -!- SUBUNIT: The phosphorylated but not the dephosphorylated form interacts
CC       with TRA2B/SFRS10 (PubMed:14765198). The dephosphorylated form
CC       interacts with SNRNP70 (PubMed:14765198). Isoform 1 interacts with FUS
CC       C-terminus (PubMed:9774382). Isoform 3 interacts with FUS C-terminus
CC       (PubMed:9774382). Interacts with YTHDC1, leading to inhibit RNA-binding
CC       activity of SRSF10 (PubMed:26876937). {ECO:0000269|PubMed:14765198,
CC       ECO:0000269|PubMed:26876937, ECO:0000269|PubMed:9774382}.
CC   -!- INTERACTION:
CC       O75494; P49759-3: CLK1; NbExp=3; IntAct=EBI-353655, EBI-11981867;
CC       O75494; P49761: CLK3; NbExp=5; IntAct=EBI-353655, EBI-745579;
CC       O75494; Q15287: RNPS1; NbExp=4; IntAct=EBI-353655, EBI-395959;
CC       O75494; P31947: SFN; NbExp=3; IntAct=EBI-353655, EBI-476295;
CC       O75494; P78362: SRPK2; NbExp=3; IntAct=EBI-353655, EBI-593303;
CC       O75494; Q07955: SRSF1; NbExp=3; IntAct=EBI-353655, EBI-398920;
CC       O75494; P62258: YWHAE; NbExp=3; IntAct=EBI-353655, EBI-356498;
CC       O75494; P61981: YWHAG; NbExp=7; IntAct=EBI-353655, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:11684676,
CC       ECO:0000269|PubMed:26876937}. Cytoplasm {ECO:0000269|PubMed:11684676}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=TASR-1;
CC         IsoId=O75494-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75494-2; Sequence=VSP_010421;
CC       Name=3; Synonyms=TASR-2, SRp38-2;
CC         IsoId=O75494-3; Sequence=VSP_010424, VSP_010425;
CC       Name=4;
CC         IsoId=O75494-4; Sequence=VSP_010422, VSP_010423, VSP_010425;
CC       Name=5;
CC         IsoId=O75494-5; Sequence=VSP_043697, VSP_043698, VSP_010423,
CC                                  VSP_010425;
CC       Name=6;
CC         IsoId=O75494-6; Sequence=VSP_010421, VSP_010424, VSP_010425;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11684676,
CC       ECO:0000269|PubMed:11891055}.
CC   -!- PTM: Phosphorylated. Fully dephosphorylated in mitosis and partially
CC       dephosphorylated on heat shock. {ECO:0000269|PubMed:12419250,
CC       ECO:0000269|PubMed:14765198}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF047448; AAC70918.1; -; mRNA.
DR   EMBL; AF067730; AAC26727.1; -; mRNA.
DR   EMBL; AF449427; AAL57514.1; -; mRNA.
DR   EMBL; AY150180; AAN65380.1; -; mRNA.
DR   EMBL; AY150181; AAN65381.1; -; mRNA.
DR   EMBL; AF419331; AAL16665.1; -; mRNA.
DR   EMBL; AF419332; AAL16666.1; -; Genomic_DNA.
DR   EMBL; AY048592; AAL06098.1; -; Genomic_DNA.
DR   EMBL; AY048592; AAL06099.1; -; Genomic_DNA.
DR   EMBL; AK001286; BAA91601.1; -; mRNA.
DR   EMBL; AK001656; BAG50956.1; -; mRNA.
DR   EMBL; AK296175; BAG58911.1; -; mRNA.
DR   EMBL; AL590609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001107; AAH01107.1; -; mRNA.
DR   EMBL; BC005039; AAH05039.1; -; mRNA.
DR   EMBL; BC010074; AAH10074.1; -; mRNA.
DR   CCDS; CCDS30629.1; -. [O75494-3]
DR   CCDS; CCDS30630.1; -. [O75494-1]
DR   CCDS; CCDS53280.1; -. [O75494-5]
DR   CCDS; CCDS53281.1; -. [O75494-6]
DR   CCDS; CCDS53282.1; -. [O75494-2]
DR   CCDS; CCDS53283.1; -. [O75494-4]
DR   RefSeq; NP_001177934.1; NM_001191005.3. [O75494-2]
DR   RefSeq; NP_001177935.1; NM_001191006.3. [O75494-4]
DR   RefSeq; NP_001177936.1; NM_001191007.3. [O75494-6]
DR   RefSeq; NP_001177938.1; NM_001191009.3. [O75494-5]
DR   RefSeq; NP_006616.1; NM_006625.6. [O75494-3]
DR   RefSeq; NP_473357.1; NM_054016.4. [O75494-1]
DR   AlphaFoldDB; O75494; -.
DR   SMR; O75494; -.
DR   BioGRID; 115990; 300.
DR   FunCoup; O75494; 4019.
DR   IntAct; O75494; 120.
DR   MINT; O75494; -.
DR   STRING; 9606.ENSP00000420195; -.
DR   GlyGen; O75494; 3 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; O75494; -.
DR   PhosphoSitePlus; O75494; -.
DR   SwissPalm; O75494; -.
DR   BioMuta; SRSF10; -.
DR   jPOST; O75494; -.
DR   MassIVE; O75494; -.
DR   PaxDb; 9606-ENSP00000420195; -.
DR   PeptideAtlas; O75494; -.
DR   ProteomicsDB; 50048; -. [O75494-1]
DR   ProteomicsDB; 50049; -. [O75494-2]
DR   ProteomicsDB; 50050; -. [O75494-3]
DR   ProteomicsDB; 50051; -. [O75494-4]
DR   ProteomicsDB; 50052; -. [O75494-5]
DR   ProteomicsDB; 63091; -.
DR   Pumba; O75494; -.
DR   TopDownProteomics; O75494-1; -. [O75494-1]
DR   TopDownProteomics; O75494-2; -. [O75494-2]
DR   TopDownProteomics; O75494-3; -. [O75494-3]
DR   TopDownProteomics; O75494-4; -. [O75494-4]
DR   TopDownProteomics; O75494-5; -. [O75494-5]
DR   Antibodypedia; 60384; 272 antibodies from 26 providers.
DR   DNASU; 10772; -.
DR   Ensembl; ENST00000343255.9; ENSP00000344149.4; ENSG00000188529.16. [O75494-2]
DR   Ensembl; ENST00000344989.10; ENSP00000342913.5; ENSG00000188529.16. [O75494-3]
DR   Ensembl; ENST00000374452.9; ENSP00000363576.5; ENSG00000188529.16. [O75494-4]
DR   Ensembl; ENST00000453840.7; ENSP00000388991.3; ENSG00000188529.16. [O75494-6]
DR   Ensembl; ENST00000484146.6; ENSP00000419813.2; ENSG00000188529.16. [O75494-5]
DR   Ensembl; ENST00000492112.3; ENSP00000420195.1; ENSG00000188529.16. [O75494-1]
DR   GeneID; 10772; -.
DR   KEGG; hsa:10772; -.
DR   MANE-Select; ENST00000492112.3; ENSP00000420195.1; NM_054016.4; NP_473357.1.
DR   UCSC; uc057dhz.1; human. [O75494-1]
DR   AGR; HGNC:16713; -.
DR   ClinPGx; PA28427; -.
DR   CTD; 10772; -.
DR   DisGeNET; 10772; -.
DR   GeneCards; SRSF10; -.
DR   HGNC; HGNC:16713; SRSF10.
DR   HPA; ENSG00000188529; Low tissue specificity.
DR   MIM; 605221; gene.
DR   OpenTargets; ENSG00000188529; -.
DR   VEuPathDB; HostDB:ENSG00000188529; -.
DR   eggNOG; KOG0118; Eukaryota.
DR   GeneTree; ENSGT00940000154450; -.
DR   HOGENOM; CLU_012062_10_2_1; -.
DR   InParanoid; O75494; -.
DR   OMA; YMHQRNQ; -.
DR   OrthoDB; 439808at2759; -.
DR   PAN-GO; O75494; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; O75494; -.
DR   PathwayCommons; O75494; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   SignaLink; O75494; -.
DR   Agora; ENSG00000188529; -.
DR   BioGRID-ORCS; 10772; 599 hits in 1141 CRISPR screens.
DR   CD-CODE; 1A18FFC4; Paraspeckle.
DR   CD-CODE; 804901D1; Nuclear speckle.
DR   ChiTaRS; SRSF10; human.
DR   GeneWiki; FUSIP1; -.
DR   GenomeRNAi; 10772; -.
DR   Pharos; O75494; Tbio.
DR   PRO; PR:O75494; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O75494; protein.
DR   Bgee; ENSG00000188529; Expressed in ventricular zone and 204 other cell types or tissues.
DR   ExpressionAtlas; O75494; baseline and differential.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IC:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0050733; F:RS domain binding; NAS:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; NAS:UniProtKB.
DR   GO; GO:0016482; P:cytosolic transport; IEA:Ensembl.
DR   GO; GO:0006376; P:mRNA splice site recognition; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; NAS:UniProtKB.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0000375; P:RNA splicing, via transesterification reactions; IDA:UniProtKB.
DR   GO; GO:0000244; P:spliceosomal tri-snRNP complex assembly; NAS:UniProtKB.
DR   FunFam; 3.30.70.330:FF:000155; serine/arginine-rich splicing factor 10 isoform X1; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR050441; RBM.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR48034; TRANSFORMER-2 SEX-DETERMINING PROTEIN-RELATED; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Proteomics identification; Reference proteome; RNA-binding.
FT   CHAIN           1..262
FT                   /note="Serine/arginine-rich splicing factor 10"
FT                   /id="PRO_0000081593"
FT   DOMAIN          10..88
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          116..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        116..126
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        134..150
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..186
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        194..207
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        209..234
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        252..262
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         146..165
FT                   /note="NSRPTGRPRRSRSHSDNDRF -> KPNCSWNTQYSSAYYTSRKI (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043697"
FT   VAR_SEQ         147
FT                   /note="Missing (in isoform 2 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010421"
FT   VAR_SEQ         164..173
FT                   /note="RFKHRNRSFS -> SQVSKKKNER (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_010422"
FT   VAR_SEQ         165..183
FT                   /note="FKHRNRSFSRSKSNSRSRS -> PNCSWNTQYSSAYYTSRKI (in
FT                   isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12419250,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9774382"
FT                   /id="VSP_010424"
FT   VAR_SEQ         166..173
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043698"
FT   VAR_SEQ         174..183
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010423"
FT   VAR_SEQ         184..262
FT                   /note="Missing (in isoform 3, isoform 4, isoform 5 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12419250,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9774382"
FT                   /id="VSP_010425"
FT   MOD_RES         O75494-3:168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         O75494-4:158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         O75494-4:160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
SQ   SEQUENCE   262 AA;  31301 MW;  205F95D36CBBFAB4 CRC64;
     MSRYLRPPNT SLFVRNVADD TRSEDLRREF GRYGPIVDVY VPLDFYTRRP RGFAYVQFED
     VRDAEDALHN LDRKWICGRQ IEIQFAQGDR KTPNQMKAKE GRNVYSSSRY DDYDRYRRSR
     SRSYERRRSR SRSFDYNYRR SYSPRNSRPT GRPRRSRSHS DNDRFKHRNR SFSRSKSNSR
     SRSKSQPKKE MKAKSRSRSA SHTKTRGTSK TDSKTHYKSG SRYEKESRKK EPPRSKSQSR
     SQSRSRSKSR SRSWTSPKSS GH
//
